Pinnacle Associates LTD Pfizer Inc Transaction History

Pinnacle Associates LTD

$6.17 Billion
Q1 2024

A detailed history of Pinnacle Associates LTD transactions in Pfizer Inc stock. As of the latest transaction made, Pinnacle Associates LTD holds 753,299 shares of PFE stock, worth $21.1 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

753,299

Previous 784,565 3.99%

Holding current value

$21.1 Million

Previous $22.6 Million 7.45%

% of portfolio

0.34%

Previous 0.39%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $809,476 - $929,538	-31,266 Reduced 3.99%	753,299 $20.9 Million
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $1.29 Million - $1.67 Million	-49,274 Reduced 5.91%	784,565 $22.6 Million
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $969,278 - $1.13 Million	-30,205 Reduced 3.5%	833,839 $27.7 Million
Q2 2023 Jul 26, 2023	BUY	$36.12 - $41.79 $2.74 Million - $3.17 Million	75,814 Added 9.62%	864,044 $31.7 Million
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $218,456 - $284,398	-5,546 Reduced 0.7%	788,230 $32.2 Million

Q4 2022 Jan 31, 2023	BUY	$41.75 - $54.5 $97,027 - $126,658	2,324 Added 0.29%	793,776 $40.7 Million
Q4 2022 Jan 25, 2023	BUY	$41.75 - $54.5 $96,484 - $125,949	2,311 Added 0.29%	791,452 $0
Q3 2022 Oct 31, 2022	SELL	$43.76 - $53.42 $270,480 - $330,189	-6,181 Reduced 0.78%	789,141 $34.5 Million
Q2 2022 Aug 02, 2022	SELL	$46.53 - $55.17 $917,013 - $1.09 Million	-19,708 Reduced 2.42%	795,322 $41.7 Million
Q1 2022 May 05, 2022	BUY	$45.75 - $56.69 $1.56 Million - $1.93 Million	34,108 Added 4.37%	815,030 $42.2 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $293,661 - $435,303	-7,107 Reduced 0.9%	780,922 $46.1 Million
Q3 2021 Oct 19, 2021	BUY	$39.25 - $50.42 $633,220 - $813,425	16,133 Added 2.09%	788,029 $33.9 Million
Q2 2021 Aug 02, 2021	SELL	$35.91 - $40.68 $206,446 - $233,869	-5,749 Reduced 0.74%	771,896 $30.2 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $1.01 Million - $1.14 Million	30,217 Added 4.04%	777,645 $28.2 Million
Q4 2020 Jan 26, 2021	BUY	$33.47 - $42.56 $369,977 - $470,458	11,054 Added 1.5%	747,428 $27.5 Million
Q3 2020 Oct 23, 2020	BUY	$31.75 - $37.25 $387,413 - $454,524	12,202 Added 1.68%	736,374 $27 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $682,760 - $828,288	22,668 Added 3.23%	724,172 $23.7 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $1.01 Million - $1.44 Million	37,384 Added 5.63%	701,504 $22.9 Million
Q4 2019 Feb 03, 2020	SELL	$32.92 - $37.36 $15,900 - $18,044	-483 Reduced 0.07%	664,120 $26 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $7,082 - $9,184	218 Added 0.03%	664,603 $23.9 Million
Q2 2019 Aug 05, 2019	SELL	$36.98 - $41.52 $168,332 - $188,999	-4,552 Reduced 0.68%	664,385 $28.8 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $142,312 - $156,354	3,795 Added 0.57%	668,937 $28.4 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $499,379 - $569,346	-12,981 Reduced 1.91%	665,142 $29 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $249,769 - $302,955	-7,246 Reduced 1.06%	678,123 $29.9 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $240,786 - $256,703	-7,301 Reduced 1.05%	685,369 $24.9 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $499,231 - $579,177	-15,645 Reduced 2.21%	692,670 $24.6 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $529,399 - $561,710	-15,917 Reduced 2.2%	708,315 $25.7 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $1.2 Million - $1.32 Million	-38,777 Reduced 5.08%	724,232 $25.9 Million
Q2 2017 Aug 09, 2017	BUY	N/A	763,009	763,009 $25.6 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Pfizer Inc Transaction History